Supply and procurement

in page functions

07 July 2014

Measles-rubella vaccine roadmap: public summary

The GAVI Alliance began funding measles-rubella (MR) vaccine catch-up campaigns iin 2011. This document is the public summary of the supply and procurement roadmap for MR, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

07 July 2014

Japanese encephalitis vaccine roadmap: public summary

The GAVI Alliance opened a funding window for Japanese encephalitis (JE) vaccination catch-up campaigns in endemic countries at its November 2013 Board meeting. This document is the public summary of the supply and procurement roadmap for JE, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

31 October 2013

Rotavirus Roadmap Public Summary

Rotavirus is the leading cause of severe diarrhoea in children under five years of age worldwide. GAVI’s rotavirus vaccine programme was initiated in 2011. This document is the public summary of the supply and procurement roadmap for rotavirus vaccine, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

31 October 2013

IPV Roadmap Public Summary

In 2013, the GAVI Board decided to begin supporting the introduction of inactivated polio vaccine (IPV) as part of routine immunisation programmes in the world’s 73 poorest countries. This document is the public summary of the supply and procurement roadmap for IPV, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

30 July 2013

Yellow Fever Roadmap Public Summary

In support of WHO efforts to control the disease, GAVI has been engaged in Yellow Fever (YF) vaccination since 2001. Yellow fever vaccination reduces the burden of a disease that has no cure, 90% of which is reported in the African region.

30 July 2013

Penta Roadmap Public Summary

The development of hepatitis B (hepB) and Haemophilus influenzae type b (Hib) vaccination through the uptake of pentavalent routine immunization represents the most significant GAVI achievement to date.

30 October 2012

GAVI Vaccine Supply and Procurement Strategy 2011-2015

1 The GAVI Alliance Vaccine Supply and Procurement Strategy for the period 2011-2015 VERSION NUMBER APPROVAL PROCESS DATE 1.0 Reviewed by: GAVI Programme and Policy Committee 28 September 2011 Approved by: GAVI Alliance Board 17 November 2011 Effective from: approval date Review: in 2014, in preparation for the develop

30 October 2012

HPV Supply and Procurement Roadmap

HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 1 PUBLIC SUMMARY Supply and Procurement Roadmap HPV (Human Papilloma Virus) Vaccine The market-shaping goal Shape vaccine markets to provide appropriate and affordable vaccines HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 2 The G

01 September 2011

Consolidated comments from public consultation on GAVI’s draft Vaccine Supply and Procurement Strategy

In July 2011 the GAVI Secretariat launched a public consultation process on the draft Vaccine Supply and Procurement Strategy for 2011-2015. The consultation was open from 4 to 29 July 2011. This document provides an overview of the process, as well as a summary of the main themes that emerged from the comments received.

07 July 2011

GAVI Alliance’s Draft Vaccine Supply and Procurement Strategy 2011-2015: for public comments

In order to achieve its market shaping objectives, GAVI is redesigning its vaccine supply and procurement strategy. This document outlines the objectives and strategies, and describes the supply and procurement mechanisms by which the new strategy will be effected.

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please




close icon

modal window here